These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1347330)

  • 1. [Proton pump inhibitors: their merits and demerits, and perspectives for future investigation].
    Kamada T; Kawano S; Tsuji S
    Nihon Rinsho; 1992 Jan; 50(1):53-9. PubMed ID: 1347330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M; Kato M; Sato Y; Miyazaki T
    Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [H2-receptor antagonist-refractory ulcer--its pathophysiology and role of proton-pump inhibitors].
    Arakawa T
    Nihon Rinsho; 1992 Jan; 50(1):122-30. PubMed ID: 1347325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
    Nagaya H; Satoh H
    Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
    Yukawa K; Yukawa E
    Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

  • 8. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer].
    Asaki S; Kimpara T; Ohara S; Hongo M
    Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibition for acid-related disease.
    Holt S
    South Med J; 1991 Sep; 84(9):1078-87. PubMed ID: 1653998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cause and prevention of nocturnal gastric acid breakthrough].
    Adachi K; Kinoshita Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():779-83. PubMed ID: 11979888
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].
    Okabe S
    Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):351-60. PubMed ID: 2873085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effect of proton pump inhibitors on reflux esophagitis].
    Sekiguchi T; Horikoshi T; Nishioka T; Kusano M
    Nihon Rinsho; 1992 Jan; 50(1):131-7. PubMed ID: 1311780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
    Kawata H; Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():640-4. PubMed ID: 11979862
    [No Abstract]   [Full Text] [Related]  

  • 17. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
    Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
    Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of proton pump inhibitor to special conditions; Zollinger-Ellison syndrome].
    Tani N
    Nihon Rinsho; 1992 Jan; 50(1):154-9. PubMed ID: 1347327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810)].
    Kawai T; Ikeda H; Harada Y; Saitou T
    Nihon Rinsho; 1992 Jan; 50(1):188-93. PubMed ID: 1311785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.